SCHEDULE: BlackRock Updates Baxter Stake to 5.9%

BlackRock Portfolio Management LLC has updated its beneficial ownership filing for Baxter International Inc., reporting a 5.9% stake as of September 30, 2026.

Summary

• BlackRock Portfolio Management LLC has filed an amendment to its Schedule 13G, reporting its beneficial ownership of Baxter International Inc. common stock.
• As of September 30, 2026, BlackRock Portfolio Management LLC beneficially owns 30,382,653 shares of Baxter International Inc. common stock.
• This represents 5.9% of the class of securities.
• The filing indicates sole voting power over 29,760,559 shares and sole dispositive power over 30,382,653 shares.
• The filing is made in accordance with Rule 13d-1(b) and BlackRock Portfolio Management LLC is classified as a 'HC' (likely referring to a holding company or investment advisor role in this context).

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a neutral filing, primarily an update on beneficial ownership by a large institutional investor, with no new strategic or financial performance information.

Positives

• BlackRock maintains a significant, though not controlling, stake in Baxter International Inc., indicating continued institutional interest.
• The filing clearly delineates voting and dispositive power, providing transparency to the market.

Negatives

• The filing does not contain any new financial performance data or strategic updates for Baxter International Inc.

Risks

• As this is a Schedule 13G filing, it primarily reports ownership and does not inherently contain forward-looking risk disclosures for Baxter International Inc. itself. The risks associated with Baxter's business would be found in other SEC filings.

Future Outlook

This filing is an ownership update and does not contain forward-looking statements or guidance regarding Baxter International Inc.'s future performance.

Management Comments

• "In accordance with SEC Release No. 34-39538 (January 12, 1998), this Schedule 13G reflects the securities beneficially owned, or deemed to be beneficially owned, by certain business units (collectively, the "Reporting Business Units") of BlackRock, Inc. and its subsidiaries and affiliates. It does not include securities, if any, beneficially owned by other business units whose beneficial ownership of securities are disaggregated from that of the Reporting Business Units in accordance with such release."
• "Various persons have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of the common stock of BAXTER INTERNATIONAL. No one person's interest in the common stock of BAXTER INTERNATIONAL is more than five percent of the total outstanding common shares."
• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine for large institutional investors like BlackRock. This filing indicates BlackRock's ongoing investment in the healthcare sector, specifically in Baxter International Inc., a significant player in medical devices and healthcare solutions.

Comparison to Industry Standards

• This filing is a standard Schedule 13G, which is a common disclosure for institutional investors exceeding a 5% beneficial ownership threshold in a public company. It does not provide performance metrics for comparison.

Stakeholder Impact

• Shareholders: The filing provides transparency regarding a significant institutional investor's holdings, which can influence market perception and trading activity.
• Management of Baxter International Inc.: The filing confirms BlackRock's passive investment approach, not seeking to influence control, which is typical for a Schedule 13G filer.

Next Steps

• BlackRock Portfolio Management LLC will continue to report any changes in its beneficial ownership of Baxter International Inc. in accordance with SEC regulations.
• Baxter International Inc. will continue its operations and financial reporting as usual.

Key Dates

Keywords

Baxter International Inc., BlackRock, Beneficial Ownership, Schedule 13G, Institutional Investor, Common Stock, Ownership Update